SL
Silexion Therapeutics Ltd. (SLXN)
NASDAQ·Healthcare·Biotechnology
$0.12
-17.36%
Mkt Cap $62.14K
No analyst coverage available
We don't have analyst ratings or price target data for Silexion Therapeutics Ltd. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.